Professional Medical Expertise Company

SASE:9574 Stock Report

Market Cap: ر.س364.0m

Professional Medical Expertise Management

Management criteria checks 1/4

Professional Medical Expertise's CEO is Amr Mahmoud Elamayem, appointed in Mar 2011, has a tenure of 13.92 years. directly owns 2.12% of the company’s shares, worth SAR7.70M. The average tenure of the management team and the board of directors is 3.1 years and 2.5 years respectively.

Key information

Amr Mahmoud Elamayem

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.9yrs
CEO ownership2.1%
Management average tenure3.1yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

CEO

Amr Mahmoud Elamayem (43 yo)

13.9yrs

Tenure

Dr. Amr Mahmoud Abu Elamayem is Executive Vice Chairman of Professional Medical Expertise Company from August 04, 2022 and serves as its Managing Director since March 14, 2011. Dr. Elamayem holds Master’s...

Leadership Team

NamePositionTenureCompensationOwnership
Amr Mahmoud Elamayem
Vice Chairman & MD13.9yrsno data2.12%
SAR 7.7m
Tamer El Akkad
Finance Manager2.9yrsno datano data
Moetaz Ahmed
Operations Manager3.1yrsno datano data
Bandar Abdulaziz Al Saeed
Human Resources Manager3.1yrsno datano data
Mohammed Al Modhayan
Director of Regulatory Affairs2.5yrsno datano data

3.1yrs

Average Tenure

43yo

Average Age

Experienced Management: 9574's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Amr Mahmoud Elamayem
Vice Chairman & MD2.5yrsno data2.12%
SAR 7.7m
Mohammed Al Modhayan
Director of Regulatory Affairs2.2yrsno datano data
Abdulillah Abdullah Zahid
Independent Director2.5yrsno datano data
Mohammad Sulaiman Al Harbi
Independent Director2.5yrsno datano data
Sameer Al-Omran
Independent Chairman2.5yrsno datano data
Talal Al Abdulkareem
Non-Executive Director3.2yrsno datano data

2.5yrs

Average Tenure

51yo

Average Age

Experienced Board: 9574's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/21 18:58
End of Day Share Price 2025/02/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Professional Medical Expertise Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.